Global Burden of Cutaneous Malignant Melanoma from 1990 to 2021
Author Information
Author(s): Liu Chengling, Liu Xingchen, Hu Li, Li Xin, Xin Haiming, Zhu Sailin
Primary Institution: The 924th Hospital of Joint Logistics Support Force of the People’s Liberation Army (PLA), Guilin, China
Hypothesis
Understanding regional differences in CMM prevalence and trends is crucial for developing targeted strategies.
Conclusion
CMM poses an increasing global health concern, with prevalence steadily rising, particularly in low SDI regions.
Supporting Evidence
- In 2021, the global prevalence of CMM reached 833,215 cases, a 161.3% increase since 1990.
- The ASPR rose from 19.13 to 25.37 per 100,000 from 1990 to 2021.
- The ASMR declined from 0.84 to 0.73 per 100,000 during the same period.
- DALYs increased by 60.5%, from 1,045,777 to 1,678,836.
- By 2045, the global ASPR is projected to rise to 36.61.
Takeaway
This study looks at how many people have skin cancer called melanoma and how it's changing over time in different parts of the world.
Methodology
The study analyzed data from the Global Burden of Diseases survey, covering 204 countries and territories, using various statistical models to evaluate prevalence, mortality, and DALYs.
Potential Biases
Underreporting and incomplete data collection in low- and middle-income countries could lead to an underestimation of the true burden of CMM.
Limitations
The accuracy of findings is contingent on the quality of cancer registries, and the predictive models do not account for potential breakthroughs in treatment or changes in public health interventions.
Participant Demographics
Individuals aged 15 to 95+ years across 204 countries and territories.
Statistical Information
Confidence Interval
95% UI
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website